7 - Acyclovir should be used for the empiric management of febrile neonates < 4 weeks undergoing full sepsis evaluation - PRO

Monday, May 1, 2023

2:00 PM – 2:15 PM ET

Location: Convention Center: 146 A

Speaker(s)

Asuncion Mejias, MD, PhD, MsCS (she/her/hers)
Professor of Pediatrics Principal Investigator, Abigail Wexner Research Institute at Nationwide Children's Hospital Attending Physician, Division of Pediatric Infectious Diseases, Nationwide Children's Hospital
St Jude Children's Research Hospital
Memphis, Tennessee, United States

Disclosure(s):

Asuncion Mejias, MD, PhD, MsCS: Astra-Zeneca (Terminated, November 15, 2022) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness); Janssen (Terminated, December 31, 2022) (Products/Services: Advisory Committee, Research Support including clinical trials & the principal or named investigator); Merck (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Pfizer (Ongoing) (Products/Services: Advisory Committee); Sanofi-Pasteur (Ongoing) (Products/Services: Advisory Committee)